| CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes P Liang, Y Xu, X Zhang, C Ding, R Huang, Z Zhang, J Lv, X Xie, Y Chen, ... Protein & cell 6 (5), 363-372, 2015 | 1621 | 2015 |
| Drug resistance and new therapies in colorectal cancer K Van der Jeught, HC Xu, YJ Li, XB Lu, G Ji World Journal of Gastroenterology 24 (34), 3834, 2018 | 504 | 2018 |
| Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer J Xu, Y Liu, Y Li, H Wang, S Stewart, K Van der Jeught, P Agarwal, ... Nature nanotechnology, 1, 2019 | 120 | 2019 |
| PTIP associates with Artemis to dictate DNA repair pathway choice J Wang, A Aroumougame, M Lobrich, Y Li, D Chen, J Chen, Z Gong Genes & development 28 (24), 2693-2698, 2014 | 120 | 2014 |
| Whole-genome screening identifies proteins localized to distinct nuclear bodies K Fong, Y Li, W Wang, W Ma, K Li, RZ Qi, D Liu, Z Songyang, J Chen J Cell Biol 203 (1), 149-164, 2013 | 111 | 2013 |
| Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation H Xu, K Van der Jeught, Z Zhou, L Zhang, T Yu, Y Sun, Y Li, C Wan, K So, ... The Journal of Clinical Investigation, 2021 | 101 | 2021 |
| Amplification of USP13 drives ovarian cancer metabolism C Han, L Yang, HH Choi, J Baddour, A Achreja, Y Liu, Y Li, J Li, G Wan, ... Nature Communications 7, 2016 | 89 | 2016 |
| Cell cycle-dependent inhibition of 53BP1 signaling by BRCA1 L Feng, N Li, Y Li, J Wang, M Gao, W Wang, J Chen Cell Discovery 1, 15019, 2015 | 86 | 2015 |
| MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation Y Fang, L Wang, C Wan, Y Sun, K Van der Jeught, Z Zhou, T Dong, ... The Journal of Clinical Investigation, 2020 | 70 | 2020 |
| Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer Y Liu, J Xu, HH Choi, C Han, Y Fang, Y Li, K Van der Jeught, H Xu, ... Nature communications 9, 2018 | 58 | 2018 |
| An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity Z Zhou, K Van der Jeught, Y Fang, T Yu, Y Li, Z Ao, S Liu, L Zhang, ... Nature Biomedical Engineering 5 (11), 1320-1335, 2021 | 55 | 2021 |
| Regulators in the DNA damage response Y Liu, Y Li, X Lu Archives of biochemistry and biophysics 594, 18-25, 2016 | 55 | 2016 |
| TOE1 acts as a 3′ exonuclease for telomerase RNA and regulates telomere maintenance T Deng, Y Huang, K Weng, S Lin, Y Li, G Shi, Y Chen, J Huang, D Liu, ... Nucleic acids research, 2018 | 54 | 2018 |
| Proteomic Analysis of the Human Cyclin-dependent Kinase Family Reveals a Novel CDK5 Complex Involved in Cell Growth and Migration S Xu, X Li, Z Gong, W Wang, Y Li, BC Nair, H Piao, K Yang, G Wu, J Chen Molecular & Cellular Proteomics 13 (11), 2986-3000, 2014 | 47 | 2014 |
| Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II Y Li, Y Liu, H Xu, G Jiang, K Van der Jeught, Y Fang, Z Zhou, L Zhang, ... Nature communications 9 (1), 4394, 2018 | 38 | 2018 |
| Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer. Y Liu, H Xu, KV Jeught, Y Li, S Liu, L Zhang, Y Fang, X Zhang, ... The Journal of clinical investigation, 2018 | 36 | 2018 |
| ST2 as checkpoint target for colorectal cancer immunotherapy K Van der Jeught, Y Sun, Y Fang, Z Zhou, H Jiang, T Yu, J Yang, ... JCI insight 5 (9), 2020 | 32 | 2020 |
| Disease mutant analysis identifies a new function of DAXX in telomerase regulation and telomere maintenance M Tang, Y Li, Y Zhang, Y Chen, W Huang, D Wang, AJ Zaug, D Liu, ... J Cell Sci 128 (2), 331-341, 2015 | 31 | 2015 |
| FOXP3 exon 2 controls Treg stability and autoimmunity J Du, Q Wang, S Yang, S Chen, Y Fu, S Spath, P Domeier, D Hagin, ... Science Immunology 7 (72), eabo5407, 2022 | 29 | 2022 |
| Akt regulates TPP1 homodimerization and telomere protection X Han, D Liu, Y Zhang, Y Li, W Lu, J Chen, Z Songyang Aging cell 12 (6), 1091-1099, 2013 | 28 | 2013 |
